Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR

Christina M. Wyatt, Juhi Chaudhari, Shiyuan Miao, Zipporah Krishnasami, James Hellinger, Andrew S. Levey, Michael Ross, Lene Ryom, Amanda Mocroft, Laurence Brunet, Jennifer Fusco, Lesley A. Inker

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)734-737
Number of pages4
JournalKidney International Reports
Volume5
Issue number5
DOIs
StatePublished - May 2020

ASJC Scopus subject areas

  • Ophthalmology
  • Nephrology

Cite this

Wyatt, C. M., Chaudhari, J., Miao, S., Krishnasami, Z., Hellinger, J., Levey, A. S., Ross, M., Ryom, L., Mocroft, A., Brunet, L., Fusco, J., & Inker, L. A. (2020). Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR. Kidney International Reports, 5(5), 734-737. https://doi.org/10.1016/j.ekir.2020.01.020